Hims & Hers Health Inc (HIMS)

$6.21

-0.24

(-3.72%)▲

Market is closed - opens 7 PM, 04 Oct 2023

Insights on Hims & Hers Health Inc

  • Increasing Revenue

    Revenue is up for the last 14 quarters, 30.06M → 207.91M (in $), with an average increase of 13.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 5 quarters, -19.67M → -7.15M (in $), with an average increase of 31.6% per quarter

  • Vs PG

    In the last 1 year, Procter & Gamble Company, The has given 11.8% return, outperforming this stock by 2.9%

Performance

  • $6.19
    $6.45
    $6.21
    downward going graph

    0.4%

    Downside

    Day's Volatility :4.11%

    Upside

    3.72%

    downward going graph
  • $4.01
    $12.34
    $6.21
    downward going graph

    35.43%

    Downside

    52 Weeks Volatility :67.5%

    Upside

    49.68%

    downward going graph

Returns

PeriodHims & Hers Health IncSector (Health Care)Index (Russel 2000)
3 Months
-30.15%
-3.2%
0.0%
6 Months
-38.45%
-2.7%
0.0%
1 Year
8.95%
0.8%
-0.4%
3 Years
-59.75%
22.3%
14.9%

Highlights

Market Capitalization
1.4B
Book Value
$1.52
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.22
Wall Street Target Price
12.45
Profit Margin
-6.61%
Operating Margin TTM
-7.0%
Return On Assets TTM
-8.08%
Return On Equity TTM
-14.7%
Revenue TTM
710.7M
Revenue Per Share TTM
3.44
Quarterly Revenue Growth YOY
83.1%
Gross Profit TTM
408.7M
EBITDA
-41.4M
Diluted Eps TTM
-0.22
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.14
EPS Estimate Next Year
-0.06
EPS Estimate Current Quarter
-0.05
EPS Estimate Next Quarter
-0.05

Analyst Recommendation

Buy
    64%Buy
    35%Hold
    0
    0%Sell
Based on 17 Wall street analysts offering stock ratings for Hims & Hers Health Inc(by analysts ranked 0 to 5 stars)
Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
6
6
5
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 100.48%

Current $6.21
Target $12.45

Company Financials

FY19Y/Y Change
Revenue
82.6M
-
Net Income
-72.1M
-
Net Profit Margin
-87.29%
-
FY20Y/Y Change
Revenue
148.8M
↑ 80.18%
Net Income
-3.0M
↓ 95.77%
Net Profit Margin
-2.05%
↑ 85.24%
FY21Y/Y Change
Revenue
271.9M
↑ 82.77%
Net Income
-107.7M
↑ 3430.94%
Net Profit Margin
-39.6%
↓ 37.55%
FY22Y/Y Change
Revenue
526.9M
↑ 93.81%
Net Income
-65.7M
↓ 38.99%
Net Profit Margin
-12.46%
↑ 27.14%
Q1 FY22Q/Q Change
Revenue
101.3M
↑ 19.62%
Net Income
-16.3M
↓ 47.85%
Net Profit Margin
-16.04%
↑ 20.75%
Q2 FY22Q/Q Change
Revenue
113.6M
↑ 12.09%
Net Income
-19.7M
↑ 21.09%
Net Profit Margin
-17.33%
↓ 1.29%
Q3 FY22Q/Q Change
Revenue
144.8M
↑ 27.54%
Net Income
-18.8M
↓ 4.26%
Net Profit Margin
-13.01%
↑ 4.32%
Q4 FY22Q/Q Change
Revenue
167.2M
↑ 15.44%
Net Income
-10.9M
↓ 42.11%
Net Profit Margin
-6.52%
↑ 6.49%
Q1 FY23Q/Q Change
Revenue
190.8M
↑ 14.09%
Net Income
-10.1M
↓ 7.7%
Net Profit Margin
-5.28%
↑ 1.24%
Q2 FY23Q/Q Change
Revenue
207.9M
↑ 8.99%
Net Income
-7.2M
↓ 28.91%
Net Profit Margin
-3.44%
↑ 1.84%
FY19Y/Y Change
Total Assets
204.8M
-
Total Liabilities
18.5M
-
FY20Y/Y Change
Total Assets
205.6M
↑ 0.42%
Total Liabilities
12.1M
↓ 34.73%
FY21Y/Y Change
Total Assets
420.6M
↑ 104.53%
Total Liabilities
86.0M
↑ 611.03%
FY22Y/Y Change
Total Assets
366.3M
↓ 12.9%
Total Liabilities
54.6M
↓ 36.49%
Q1 FY22Q/Q Change
Total Assets
382.0M
↓ 9.16%
Total Liabilities
54.3M
↓ 36.81%
Q2 FY22Q/Q Change
Total Assets
380.0M
↓ 0.54%
Total Liabilities
60.9M
↑ 12.12%
Q3 FY22Q/Q Change
Total Assets
382.8M
↑ 0.75%
Total Liabilities
71.9M
↑ 18.02%
Q4 FY22Q/Q Change
Total Assets
366.3M
↓ 4.31%
Total Liabilities
54.6M
↓ 24.04%
Q1 FY23Q/Q Change
Total Assets
376.3M
↑ 2.72%
Total Liabilities
63.6M
↑ 16.41%
Q2 FY23Q/Q Change
Total Assets
389.9M
↑ 3.61%
Total Liabilities
69.8M
↑ 9.84%
FY18Y/Y Change
Operating Cash Flow
-57.3M
-
Investing Cash Flow
-8.0K
-
Financing Cash Flow
78.2M
-
FY19Y/Y Change
Operating Cash Flow
-74.9M
↑ 30.61%
Investing Cash Flow
-39.3M
↑ 491137.5%
Financing Cash Flow
95.3M
↑ 21.97%
FY20Y/Y Change
Operating Cash Flow
-777.1K
↓ 98.96%
Investing Cash Flow
-39.7M
↑ 1.02%
Financing Cash Flow
47.7M
↓ 49.91%
FY21Y/Y Change
Operating Cash Flow
-34.4M
↑ 4328.41%
Investing Cash Flow
-156.3M
↑ 293.61%
Financing Cash Flow
235.0M
↑ 392.32%
Q1 FY22Q/Q Change
Operating Cash Flow
-19.4M
↑ 524.9%
Investing Cash Flow
18.5M
↑ 80.17%
Financing Cash Flow
-22.5M
↑ 28780.77%
Q2 FY22Q/Q Change
Operating Cash Flow
-6.4M
↓ 67.05%
Investing Cash Flow
12.8M
↓ 30.53%
Financing Cash Flow
353.0K
↓ 101.57%
Q3 FY22Q/Q Change
Operating Cash Flow
6.0M
↓ 193.6%
Investing Cash Flow
-2.6M
↓ 120.1%
Financing Cash Flow
-494.0K
↓ 239.94%
Q1 FY23Q/Q Change
Operating Cash Flow
9.5M
↓ 241.14%
Investing Cash Flow
-4.1M
-
Financing Cash Flow
-3.4M
↓ 67.38%

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Hims & Hers Health Inc
Hims & Hers Health Inc
-9.87%
-38.45%
8.95%
-59.75%
-59.75%
Colgate-palmolive Co.
Colgate-palmolive Co.
-3.17%
-5.7%
-1.91%
-10.14%
8.55%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
-12.42%
-42.32%
-37.93%
-36.47%
2.86%
Procter & Gamble Company, The
Procter & Gamble Company, The
-4.56%
-3.16%
11.83%
4.38%
77.6%
Kenvue Inc.
Kenvue Inc.
-11.59%
-25.69%
-25.69%
-25.69%
-25.69%
Kimberly-clark Corp.
Kimberly-clark Corp.
-5.09%
-10.35%
3.72%
-19.38%
7.26%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Hims & Hers Health Inc
Hims & Hers Health Inc
NA
NA
NA
-0.14
-0.15
-0.08
0.0
1.52
Colgate-palmolive Co.
Colgate-palmolive Co.
39.53
39.53
3.74
2.99
0.38
0.13
0.03
-0.08
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
51.77
51.77
4.52
3.36
0.16
0.05
0.02
15.62
Procter & Gamble Company, The
Procter & Gamble Company, The
24.73
24.73
4.98
5.31
0.31
0.1
0.03
19.46
Kenvue Inc.
Kenvue Inc.
38.08
38.08
NA
1.29
0.0
0.0
0.04
5.77
Kimberly-clark Corp.
Kimberly-clark Corp.
24.54
24.54
4.01
6.45
2.36
0.1
0.04
1.48
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Hims & Hers Health Inc
Hims & Hers Health Inc
Buy
$1.4B
-59.75%
NA
-6.61%
Colgate-palmolive Co.
Colgate-palmolive Co.
Buy
$58.5B
8.55%
39.53
8.02%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
Buy
$51.7B
2.86%
51.77
6.32%
Procter & Gamble Company, The
Procter & Gamble Company, The
Buy
$343.8B
77.6%
24.73
17.87%
Kenvue Inc.
Kenvue Inc.
Buy
$40.8B
-25.69%
38.08
11.12%
Kimberly-clark Corp.
Kimberly-clark Corp.
Hold
$40.2B
7.26%
24.54
8.07%

Institutional Holdings

  • Vanguard Group Inc

    6.49%

  • BlackRock Inc

    4.71%

  • Institutional Venture Management XV, LLC

    3.65%

  • Institutional Venture Management XVI, LLC

    3.65%

  • Redpoint Management, LLC

    3.59%

  • Marshall Wace Asset Management Ltd

    2.78%

Corporate Announcements

  • Hims & Hers Health Inc Earnings

    Hims & Hers Health Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

hims, inc. manufactures men's wellness products. it offers products, including hair loss prevention medicines, sexual wellness products, skincare products, and oral care products. the company also provides sweaters, jackets, corduroy, sport coats, wool overcoat, leather boots, flannel, shirts, caps, and candles. it sells its products online. the company was incorporated in 2013 and is based in san francisco, california.

Organization
Hims & Hers Health Inc
Employees
651
CEO
Mr. Andrew Dudum
Industry
Consumer Defensive

Discover More

FAQs